Form D · Other Health Care
Cellens, Inc.
Boston, MA · CIK 0001926630
Offering snapshot reported Nov 14, 2025 · SEC filing
- Reported sold
- $6.44M Offering amount: $6.44M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $747 Reported outside-investor minimum
- First sale
- Aug 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 14, 2025 | Initial | $6,440,526 | No comparison | 33 | SEC filing |
| Oct 14, 2022 | Initial | $585,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-564086
Source: Form D, filed Nov 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lena Chaihorsky Hering | Director |
| Mohan Iyer | Director |
| Phuong Nhu Pham | Director, Executive |
| Phuong (Jean) Pham | Director, Executive |
| Jesse Salk | Director |
| Deborah Zajac | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
529 Main Street Suite 1 M6
Boston, MA, 02129
Boston, MA, 02129